Indication Bioscience Llc

This early-phase study tested the safety and how the body processes Atorvo+™ in 24 healthy adults aged 40 to 75. Participants received either the study drug or a placebo to check for side effects and measure drug levels in the blood. The goal was to gather safety information, not…